Cronos Group, Inc. (CRON)
3.35
-0.02
(-0.59%)
USD |
NASDAQ |
Sep 18, 16:00
3.345
0.00 (0.00%)
Pre-Market: 20:00
Cronos Group Market Cap : 1.242B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.242B |
| September 17, 2026 | 1.249B |
| September 16, 2026 | 1.220B |
| September 15, 2026 | 1.186B |
| September 14, 2026 | 1.199B |
| September 11, 2026 | 1.164B |
| September 10, 2026 | 1.171B |
| September 09, 2026 | 1.170B |
| September 08, 2026 | 1.181B |
| September 04, 2026 | 1.209B |
| September 03, 2026 | 1.209B |
| September 02, 2026 | 1.201B |
| September 01, 2026 | 1.253B |
| August 31, 2026 | 1.249B |
| August 28, 2026 | 1.253B |
| August 27, 2026 | 1.257B |
| August 26, 2026 | 1.316B |
| August 25, 2026 | 1.301B |
| August 24, 2026 | 1.264B |
| August 21, 2026 | 1.227B |
| August 20, 2026 | 1.194B |
| August 19, 2026 | 1.220B |
| August 18, 2026 | 1.190B |
| August 17, 2026 | 1.168B |
| August 14, 2026 | 1.164B |
| Date | Value |
|---|---|
| August 13, 2026 | 1.171B |
| August 12, 2026 | 1.175B |
| August 11, 2026 | 1.142B |
| August 10, 2026 | 1.112B |
| August 07, 2026 | 1.149B |
| August 06, 2026 | 1.138B |
| August 05, 2026 | 1.008B |
| August 04, 2026 | 1.042B |
| August 03, 2026 | 1.065B |
| July 31, 2026 | 1.065B |
| July 30, 2026 | 1.087B |
| July 29, 2026 | 1.076B |
| July 28, 2026 | 1.072B |
| July 27, 2026 | 1.076B |
| July 24, 2026 | 1.057B |
| July 23, 2026 | 1.031B |
| July 22, 2026 | 1.046B |
| July 21, 2026 | 1.054B |
| July 20, 2026 | 1.054B |
| July 17, 2026 | 1.050B |
| July 16, 2026 | 1.035B |
| July 15, 2026 | 1.031B |
| July 14, 2026 | 1.035B |
| July 13, 2026 | 1.035B |
| July 10, 2026 | 1.035B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lexaria Bioscience Corp. | 5.354M |
| Target Group, Inc. (Canada) | 0.4936M |
| Tilray Brands, Inc. | 523.06M |
| InMed Pharmaceuticals, Inc. | 7.262M |
| XORTX Therapeutics, Inc. | 3.323M |
Market Cap Related Metrics
| PE Ratio | 18.19 |
| PS Ratio | 7.129 |
| PEG Ratio | 0.0634 |
| Price to Book Value | 1.162 |
| Price to Free Cash Flow | 25.73 |
| Price | 3.35 |
| Earnings Yield | 5.50% |
| PEGY Ratio | 0.0634 |
| Normalized PE Ratio | 16.92 |